Growth Metrics

Ensysce Biosciences (ENSC) Receivables - Net (2021 - 2025)

Historic Receivables - Net for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to $8.9 million.

  • Ensysce Biosciences' Receivables - Net changed N/A to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is 8504.67% down from last year.
  • Per Ensysce Biosciences' latest filing, its Receivables - Net stood at $8.9 million for Q3 2025.
  • Ensysce Biosciences' 5-year Receivables - Net high stood at $10.7 million for Q2 2022, and its period low was $1.6 million during Q4 2024.
  • Moreover, its 5-year median value for Receivables - Net was $8.9 million (2025), whereas its average is $6.3 million.
  • Per our database at Business Quant, Ensysce Biosciences' Receivables - Net crashed by 8504.67% in 2024 and then surged by 39473.68% in 2025.
  • Ensysce Biosciences' Receivables - Net (Quarter) stood at $2.8 million in 2021, then surged by 282.14% to $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then crashed by 85.05% to $1.6 million in 2024, then skyrocketed by 456.25% to $8.9 million in 2025.
  • Its Receivables - Net stands at $8.9 million for Q3 2025, versus $9.4 million for Q2 2025 and $9.2 million for Q1 2025.